BIOTON Statistics

Total Valuation

BIOTON has a market cap or net worth of PLN 291.51 million. The enterprise value is 344.25 million.

Market Cap	291.51M
Enterprise Value	344.25M

Important Dates

The next estimated earnings date is Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	n/a

Share Statistics

BIOTON has 85.86 million shares outstanding.

Shares Outstanding	85.86M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.53%
Float	28.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.56
PB Ratio	0.49
P/FCF Ratio	13.65
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 55.20, with an EV/FCF ratio of 16.12.

EV / Earnings	-50.28
EV / Sales	1.85
EV / EBITDA	55.20
EV / EBIT	n/a
EV / FCF	16.12

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 9.46.

Current Ratio	1.04
Quick Ratio	0.20
Debt / Equity	9.46
Debt / EBITDA	9.08
Debt / FCF	2.65
Interest Coverage	-1.89

Financial Efficiency

Return on equity (ROE) is -1.14% and return on invested capital (ROIC) is -1.35%.

Return on Equity (ROE)	-1.14%
Return on Assets (ROA)	-1.12%
Return on Capital (ROIC)	-1.35%
Revenue Per Employee	521,894
Profits Per Employee	-19,176
Employee Count	357
Asset Turnover	0.23
Inventory Turnover	1.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.50% in the last 52 weeks. The beta is 0.11, so BIOTON's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-12.50%
50-Day Moving Average	3.47
200-Day Moving Average	3.53
Relative Strength Index (RSI)	44.98
Average Volume (20 Days)	20,906

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIOTON had revenue of PLN 186.32 million and -6.85 million in losses. Loss per share was -0.08.

Revenue	186.32M
Gross Profit	62.98M
Operating Income	-14.44M
Pretax Income	-3.91M
Net Income	-6.85M
EBITDA	2.26M
EBIT	-14.44M
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

The company has 3.89 million in cash and 56.63 million in debt, giving a net cash position of -52.74 million or -0.61 per share.

Cash & Cash Equivalents	3.89M
Total Debt	56.63M
Net Cash	-52.74M
Net Cash Per Share	-0.61
Equity (Book Value)	598.56M
Book Value Per Share	6.97
Working Capital	5.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 53.77 million and capital expenditures -32.42 million, giving a free cash flow of 21.35 million.

Operating Cash Flow	53.77M
Capital Expenditures	-32.42M
Free Cash Flow	21.35M
FCF Per Share	0.25

Full Cash Flow Statement

Margins

Gross margin is 33.80%, with operating and profit margins of -7.75% and -3.67%.

Gross Margin	33.80%
Operating Margin	-7.75%
Pretax Margin	-2.10%
Profit Margin	-3.67%
EBITDA Margin	1.21%
EBIT Margin	-7.75%
FCF Margin	11.46%

Dividends & Yields

BIOTON does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.35%
FCF Yield	7.32%

Stock Splits

The last stock split was on January 14, 2014. It was a reverse split with a ratio of 0.01.

Last Split Date	Jan 14, 2014
Split Type	Reverse
Split Ratio	0.01

Scores

BIOTON has an Altman Z-Score of -0.79. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.79
Piotroski F-Score	n/a